ÂÜÀòÂÒÂ×

Andrew brings 13 years of biotech industry experience focused on Business Development and Commercial Strategy in oncology and has spent 11 years as a strategy consultant working with top biopharma companies. He was originally trained as a cancer biologist and has held positions as a Research Scientist at Memorial Sloan Kettering Cancer Center and Associate at Radius Ventures. Andrew received a B.S. in Biology from Brown University, a Ph.D. in Molecular and Medical Pharmacology from the University of California Los Angeles, and an M.B.A. from Columbia Business School.